"The booklet helped me not to panic": A pilot of a decision aid for asymptomatic women with ovarian cancer and with rising CA-125 levels

International Journal of Gynecological Cancer

Volumn 21, Issue 4, 2011, Pages 737-743

  Anderson, Caroline ^a   Carter, Jonathan ^b   Nattress, Kathryn ^b   Beale, Philip ^c   Philp, Shannon ^a   Harrison, James ^a   Juraskova, Ilona ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c SYDNEY CANCER CENTRE   (Australia)

Author keywords

CA 125; Decision aid; Decision making; Ovarian carcinoma; Pilot

Indexed keywords

CA 125 ANTIGEN; TAMOXIFEN;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL DECISION MAKING; COMPREHENSION; DECISION AID BOOKLET; DECISION SUPPORT SYSTEM; FEASIBILITY STUDY; HEALTH CARE PERSONNEL; HUMAN; OVARY CANCER; PANIC; PATIENT ATTITUDE; PRIORITY JOURNAL; RECURRENT CANCER; SEMI STRUCTURED INTERVIEW;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CA-125 ANTIGEN; CARCINOMA; COMPREHENSION; DECISION MAKING; DECISION SUPPORT TECHNIQUES; FEASIBILITY STUDIES; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MEMBRANE PROTEINS; MIDDLE AGED; OVARIAN NEOPLASMS; PAMPHLETS; PANIC; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; PILOT PROJECTS; RECURRENCE; UP-REGULATION;

EID: 79956201171     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181fe8b57     Document Type: Article

References (26)

1. Meyer T, Rustin GJS. Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer. 2000;82:1535-1538. (Pubitemid 30204358)
2. Armstrong DK. Relapsed ovarian cancer: challenges and management: strategies for a chronic disease. Oncologist. 2002;7(suppl 5):20-28.
3. Peters-Engl C, Obermair A, Heinzi H, et al. CA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer. Br J Cancer. 1999;81:662-666. (Pubitemid 29458862)
4. Grounland B, Hansen HH, Hogdall C, et al. Do CA125 response rate criteria overestimate tumour response in second-line treatment of epithelia ovarian cancer? Br J Cancer. 2004;90:377-382. (Pubitemid 38250632)
5. Rustin GJ, van der Burg ME. A randomized trial in ovarian cancer (OC) of early treatment of relapse based on CA125 level alone versus delayed treatment based on conventional clinical indicators (MRC OV05/EORTC 55955 trials). J Clin Oncol. 2009;27:abstr 1.
6. Harrison JD, Juraskova I, Anderson C, et al. Rising cancer antigen 125 level and the type and timing of treatment for recurrent ovarian cancer: a clinical dilemma, but what would women do? Int J Gynecol Cancer. 2009;19:1037-1046.
7. Howell D, Fitch MI, Deane KA. Women's experiences with recurrent ovarian cancer. Cancer Nurs. 2003;26:1-9. (Pubitemid 36152250)
8. Guidozzi F. Living with ovarian cancer. Gynecol Oncol. 1993;50:202-207. (Pubitemid 23275205)
9. Parker PA, Kudelka A, Basen-Engquist K, et al. The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer. Gynecol Oncol. 2006;100:495-500. (Pubitemid 43246864)
10. Trevena L, Davey H, Barratt A, et al. A systematic review on communicating with patients about evidence. J Eval Clin Pract. 2006;12:13-23. (Pubitemid 43219515)
11. O'Connor AM, Stavey D, Entwhisle V, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2003;CD001431.
12. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or at least it takes two to tango). Soc Sci Med. 1997;44:681-692. (Pubitemid 27067502)
13. Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med. 1999;49:651-661. (Pubitemid 29314682)
14. O'Connor AM, Mulley AG Jr, Wennberg JE. Standard consultations are not enough to ensure decision quality regarding preference-sensitive options. J Natl Cancer Inst. 2003;95:570-571. (Pubitemid 36553496)
15. Kessels RPC. Patients' memory for medical information. J R Soc Med. 2003;96:219-222. (Pubitemid 36561066)
16. Ottawa Hospital Research Institute. Cochrane Decision Aid Library Inventory (DALI), 2007-2009. Available at: http:// decisionaid.ohri.ca/ cochinvent.php. Accessed July 1, 2007.
17. Elwyn G, O'Connor A, Stacey D, et al. International Patient Decision Aid Standards (IPDAS) Collaboration. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006; 333:417.
18. Cassileth BR, Zupkis RV, Sutton-Smith K, et al. Information and participation preferences among cancer patients. Ann Intern Med. 1980;92:832-836. (Pubitemid 10124374)
19. O'Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995;15:25-30.
20. Speilberger CD. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
21. Marteau TM, Bekker H. The development of a six-item short form of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psych. 1992;31:301-306.
22. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77-101.
23. Leech NL, Onwuegbuzie AJ. Qualitative data analysis: a compendium of techniques and a framework for selection for school psychology research and beyond. School Psychol Q. 2008;23:587-604.
24. Sukegawa A, Miyagi E, Asai-Sato M, et al. Anxiety and prevalence of psychiatric disorders among patients awaiting surgery for suspected ovarian cancer. J Obstet Gynaecol Res. 2008;34:543-551.
25. O'Connor AM, Jacobsen, MJ, Stacey D. An evidence-based approach to managing women's decisional conflict. J Obstet Gynecol Neonatal Nurs. 2009;31:570-581.
26. Chitale R. Monitoring ovarian cancer: CA125 trial stirs controversy. J Natl Cancer Inst. 2009;101:1233-1235.